Issue of Equity

Zotefoams PLC

07 May 2026

 

Zotefoams plc

Issue of Equity

7 May 2026 - Zotefoams plc (LSE: ZTF) announces that it has conditionally agreed to allot and issue 400,000 new ordinary shares of five pence each in the capital of the Company ("Ordinary Shares") on 13 May 2026, (the "New Shares").

The New Shares, which will rank pari passu with the existing Ordinary Shares in issue, will be allotted and issued to the Zotefoams plc 2007 Employee Benefit Trust (the "EBT") at the par value of five pence each in order to satisfy future exercises of awards under the Group's share incentive schemes.

The EBT will thereafter hold a total of 464,355 Ordinary Shares, representing approximately 0.94 percent of the enlarged issued share capital of the Company.

Applications have been made to the Financial Conduct Authority (the "FCA") for the admission of the New Shares to the equity shares (commercial companies) category of the Official List of the FCA and to London Stock Exchange plc for admission to trading of the New Shares on its main market for listed securities (together, "Admission"). Admission is expected to become effective at 8.00 a.m. on 13 May 2026

The allotment and issue of the New Shares are conditional upon Admission becoming effective.

Following Admission, the Company will have 49,646,234 Ordinary Shares in issue. There are no Ordinary Shares held in treasury. Therefore, following Admission the total number of voting rights in the Company will be 49,646,234 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their voting rights interest, or a change to that interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

Enquiries:

Zotefoams plc		[phone]
Ronan Cox, Group CEO
Nick Wright, Group CFO
IFC Advisory (Financial PR & IR)		[phone]
Graham Herring

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in high-performance foam technology delivering optimal material solutions for the benefit of society. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE^® polyolefin and ZOTEK^® high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT^® advanced insulation for demanding industrial markets.

Zotefoams is headquartered in London, UK, with manufacturing sites in Croydon, UK, Kentucky, USA and Brzeg, Poland (foam manufacture), Oklahoma, USA (foam products manufacture and conversion), Anglesola and Burgos, Spain (foam manufacture) and Jiangsu Province, China (T-FIT).

www.zotefoams.com

AZOTE^®, ZOTEK^®, ReZorce^® and T-FIT^® are registered trademarks of Zotefoams plc

 

END